DTYMK and hepatocellular carcinoma: In this study, the growth of Huh7 and Hep3B HCC cells and the expression of cell cycle proteins CDK2, CDK4, Cyclin A2, and Cyclin D1, which were involved in the G0/G1 and S phases, significantly reduced after DTYMK knockdown.